help button home button Endocrine Society Molecular Endocrinology ENDO 08 Sessions Library
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH

This version published online on August 15, 2002
Molecular Endocrinology, doi:10.1210/me.2002-0111
Molecular Endocrinology Vol. 0, No. 2002 200201111-
doi:10.1210/me.2002-0111
Copyright © 2002 by the Endocrine Society.
This Article
Right arrow Author Manuscript (PDF)
Right arrow All Versions of this Article:
16/11/2490    most recent
Author Manuscript (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dong, M.
Right arrow Articles by Miller, L. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dong, M.
Right arrow Articles by Miller, L. J.

Submitted on March 19, 2002
Accepted on July 26, 2002

Interaction between four residues distributed through the secretin pharmacophore and a focused region of the secretin receptor amino terminus

Maoqing Dong1, Mengwei Zang1, Delia I. Pinon1, Zhijun Li1, Terry P. Lybrand1, and Laurence J. Miller1*

1 From Center for Basic Research in Digestive Diseases, Departments of Internal Medicine and Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic and Foundation, Rochester, MN 55905 and Vanderbilt University, Department of Chemistry and Center for Structural Biology, Nashville, TN 37232-8725 For consideration of publication in Molec. Endocrinol.

* To whom correspondence should be addressed. E-mail: miller{at}mayo.edu.

The amino terminus of the secretin receptor is known to be critical for natural agonist action, although the role it plays is still unclear. We have demonstrated that photolabile residues within both the amino-terminal (position 6) and carboxyl-terminal (positions 22 and 26) halves of secretin each covalently label receptor amino-terminal tail residues (1{ndash}3). Here, we extend this series of studies with an additional probe having its site of covalent attachment in a distinct region of the peptide, between amino- and carboxyl-terminal helical domains. This probe incorporated a photolabile ({epsilon}-p-benzoylbenzoyl)lysine in position 18 and a site for oxidative radioiodination ([Tyr10,(BzBz)Lys18]rat secretin-27). This analog represented a full agonist, stimulating cAMP accumulation in CHO-SecR cells in a concentration-dependent manner. It bound to the secretin receptor specifically and saturably, and was able to efficiently label that molecule within its amino terminus. Sequential specific cleavage, purification, and sequencing demonstrated that this probe labeled receptor residue Arg14, in the same subdomain as that labeled by previous probes. Consistent with the importance of this residue, Ala replacement mutagenesis (R14A) resulted in substantial reductions in the potency (127-fold) and binding affinity (400-fold) of secretin relative to its action at the wild type receptor. We have been able to accommodate all four extant pairs of residue-residue approximations between divergent regions of the secretin pharmacophore and the first forty residues of the secretin receptor into a credible molecular model of this interaction. Additional experimentally-derived constraints will be necessary to determine the spatial positioning of this complex with the remainder of the secretin receptor.


Key words: secretin receptor • G protein-coupled receptors • ligand-binding domain • photoaffinity labeling




This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
M. Dong, P. C.-H. Lam, D. I. Pinon, P. M. Sexton, R. Abagyan, and L. J. Miller
Spatial Approximation between Secretin Residue Five and the Third Extracellular Loop of Its Receptor Provides New Insight into the Molecular Basis of Natural Agonist Binding
Mol. Pharmacol., August 1, 2008; 74(2): 413 - 422.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. G. Harikumar, P. C.-H. Lam, M. Dong, P. M. Sexton, R. Abagyan, and L. J. Miller
Fluorescence Resonance Energy Transfer Analysis of Secretin Docking to Its Receptor: MAPPING DISTANCES BETWEEN RESIDUES DISTRIBUTED THROUGHOUT THE LIGAND PHARMACOPHORE AND DISTINCT RECEPTOR RESIDUES
J. Biol. Chem., November 9, 2007; 282(45): 32834 - 32843.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
C. S. Lisenbee, K. G. Harikumar, and L. J. Miller
Mapping the Architecture of Secretin Receptors with Intramolecular Fluorescence Resonance Energy Transfer Using Acousto-Optic Tunable Filter-Based Spectral Imaging
Mol. Endocrinol., August 1, 2007; 21(8): 1997 - 2008.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Dong, P. C.-H. Lam, F. Gao, K. Hosohata, D. I. Pinon, P. M. Sexton, R. Abagyan, and L. J. Miller
Molecular Approximations between Residues 21 and 23 of Secretin and Its Receptor: Development of a Model for Peptide Docking with the Amino Terminus of the Secretin Receptor
Mol. Pharmacol., August 1, 2007; 72(2): 280 - 290.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Dong, K. Hosohata, D. I. Pinon, N. Muthukumaraswamy, and L. J. Miller
Differential Spatial Approximation between Secretin and Its Receptor Residues in Active and Inactive Conformations Demonstrated by Photoaffinity Labeling
Mol. Endocrinol., July 1, 2006; 20(7): 1688 - 1698.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Dong, D. I. Pinon, Y. W. Asmann, and L. J. Miller
Possible Endogenous Agonist Mechanism for the Activation of Secretin Family G Protein-Coupled Receptors
Mol. Pharmacol., July 1, 2006; 70(1): 206 - 213.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
T. Dean, A. Linglart, M. J. Mahon, M. Bastepe, H. Juppner, J. T. Potts Jr., and T. J. Gardella
Mechanisms of Ligand Binding to the Parathyroid Hormone (PTH)/PTH-Related Protein Receptor: Selectivity of a Modified PTH(1-15) Radioligand for G{alpha}S-Coupled Receptor Conformations
Mol. Endocrinol., April 1, 2006; 20(4): 931 - 943.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
K. G. Harikumar, K. Hosohata, D. I. Pinon, and L. J. Miller
Use of Probes with Fluorescence Indicator Distributed throughout the Pharmacophore to Examine the Peptide Agonist-binding Environment of the Family B G Protein-coupled Secretin Receptor
J. Biol. Chem., February 3, 2006; 281(5): 2543 - 2550.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
M. Dong, D. I. Pinon, and L. J. Miller
Insights into the Structure and Molecular Basis of Ligand Docking to the G Protein-Coupled Secretin Receptor Using Charge-Modified Amino-Terminal Agonist Probes
Mol. Endocrinol., July 1, 2005; 19(7): 1821 - 1836.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
C. S. Lisenbee, M. Dong, and L. J. Miller
Paired Cysteine Mutagenesis to Establish the Pattern of Disulfide Bonds in the Functional Intact Secretin Receptor
J. Biol. Chem., April 1, 2005; 280(13): 12330 - 12338.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Shimizu, T. Dean, J. C. Tsang, A. Khatri, J. T Potts Jr, and T. J. Gardella
Novel Parathyroid Hormone (PTH) Antagonists That Bind to the Juxtamembrane Portion of the PTH/PTH-related Protein Receptor
J. Biol. Chem., January 21, 2005; 280(3): 1797 - 1807.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Dong, D. I. Pinon, R. F. Cox, and L. J. Miller
Molecular Approximation between a Residue in the Amino-terminal Region of Calcitonin and the Third Extracellular Loop of the Class B G Protein-coupled Calcitonin Receptor
J. Biol. Chem., July 23, 2004; 279(30): 31177 - 31182.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
V. Pham, J. D. Wade, B. W. Purdue, and P. M. Sexton
Spatial Proximity between a Photolabile Residue in Position 19 of Salmon Calcitonin and the Amino Terminus of the Human Calcitonin Receptor
J. Biol. Chem., February 20, 2004; 279(8): 6720 - 6729.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Dong, Z. Li, D. I. Pinon, T. P. Lybrand, and L. J. Miller
Spatial Approximation between the Amino Terminus of a Peptide Agonist and the Top of the Sixth Transmembrane Segment of the Secretin Receptor
J. Biol. Chem., January 23, 2004; 279(4): 2894 - 2903.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Dong, D. I. Pinon, R. F. Cox, and L. J. Miller
Importance of the Amino Terminus in Secretin Family G Protein-coupled Receptors: INTRINSIC PHOTOAFFINITY LABELING ESTABLISHES INITIAL DOCKING CONSTRAINTS FOR THE CALCITONIN RECEPTOR
J. Biol. Chem., January 9, 2004; 279(2): 1167 - 1175.
[Abstract] [Full Text] [PDF]


Home page
Mol. Endocrinol.Home page
R. C. Gensure, N. Shimizu, J. Tsang, and T. J. Gardella
Identification of a Contact Site for Residue 19 of Parathyroid Hormone (PTH) and PTH-Related Protein Analogs in Transmembrane Domain Two of the Type 1 PTH Receptor
Mol. Endocrinol., December 1, 2003; 17(12): 2647 - 2658.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
M. Dong, Z. Li, M. Zang, D. I. Pinon, T. P. Lybrand, and L. J. Miller
Spatial Approximation between Two Residues in the Mid-region of Secretin and the Amino Terminus of Its Receptor: INCORPORATION OF SEVEN SETS OF SUCH CONSTRAINTS INTO A THREE-DIMENSIONAL MODEL OF THE AGONIST-BOUND SECRETIN RECEPTOR
J. Biol. Chem., November 28, 2003; 278(48): 48300 - 48312.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. Zang, M. Dong, D. I. Pinon, X.-Q. Ding, E. M. Hadac, Z. Li, T. P. Lybrand, and L. J. Miller
Spatial Approximation between a Photolabile Residue in Position 13 of Secretin and the Amino Terminus of the Secretin Receptor
Mol. Pharmacol., May 1, 2003; 63(5): 993 - 1001.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
K. E. Mayo, L. J. Miller, D. Bataille, S. Dalle, B. Goke, B. Thorens, and D. J. Drucker
International Union of Pharmacology. XXXV. The Glucagon Receptor Family
Pharmacol. Rev., March 1, 2003; 55(1): 167 - 194.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society